Navigation Links
EndyMed Medical Receives FDA Clearance for Painless, Non-invasive Anti-Wrinkle Treatment System
Date:8/21/2009

CAESAREA, Israel, August 17 /PRNewswire/ -- EndyMed Medical Ltd, an innovative developer of noninvasive, energy-based aesthetic treatment systems for the professional market, announced today the FDA clearance of the EndyMed PRO(TM) (previously Imagine), for the non-invasive treatment of facial wrinkles and rhytides.

The EndyMed PRO implements the third generation 3DEEP(TM) radio frequency (RF) technology which uses multiple, phase controlled sources, and is the first product of this type to receive clearance to be marketed in the USA.

3DEEP(TM) uniquely controls the power, depth and 3-dimensional pattern of RF energy delivered to the skin. The 3DEEP technology results in minimal surface energy flow, thus eliminating the need for cooling, and providing an effective contouring treatment that is personalized, safe & totally painless.

"FDA clearance establishes our company as a significant player in the worldwide aesthetics market," said Uzi Blumensohn, EndyMed CEO. "Our 3DEEP Technology platform is proven to be highly effective in the treatment of facial wrinkles and importantly, has long-lasting effects, an important benefit for both physicians and their patients."

In a multicenter clinical study examining the safety and efficacy of the EndyMed PRO(TM) wrinkle reduction system, dermatological evaluation concluded that a significant reduction of wrinkle grading was evidenced in more than 80 percent of the treated patients, three months after the end of the treatment.

The advanced EndyMed PRO is equipped with a range of features to assure effective and safe treatment:

    - Non-invasive, yet highly effective therapy for the reduction of
      wrinkles and rhytides.
    - Customized treatment parameters
    - Optimal safety, with no pain and no side effects
    - Short treatment with no downtime
    - Noticeable immediate improvement
    - Long term r
'/>"/>
SOURCE EndyMed Medical Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Eclipsemed, Ltd to Introduce EndyMed PRO(TM) to U.S. Aesthetic Market
2. Elizabeth McCaughey Resigns As Director of Cantel Medical
3. Symmetry Medical to Present at Thomas Weisel Partners 2009 Healthcare Conference
4. Recent Article Reveals Medical Ghostwriting Suppressed Links Between Synthetic Hormones and Breast Cancer
5. Online Think Tank Big Think Launches New Multimedia Web Series Exploring Some of the Most Pressing Science and Medical Issues of our Time
6. Medical Heroin Helps Treatment-Resistant Addicts
7. How Well Do You Sleep At Night? Visit The New Online Aviisha Medical Wellness Institute To Find Out
8. Rapid Fire Marketing Enters Medical Cannabis Business
9. Mindray Medical to Present at the Morgan Stanley Global Healthcare Unplugged Conference
10. American Podiatric Medical Association Corrects Presidents Misstatement on Foot Amputation Costs
11. Johnson City Medical Center Saves $550,000 with Smart Square(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... governance, and compliance software solutions for next-generation social ... Inc. magazine’s Inc. 500|5000, an exclusive ranking of ... consecutive year. AvePoint joins brands such as Alex ... 2014 edition. , This underscores continued growth ...
(Date:8/27/2014)... BambooIndustry.com is one of the most loved online bamboo product ... sale now. Recently, it has announced its new selection of ... BambooIndustry.com strives to offer one-stop shopping solutions for people who ... Now, it is providing big discounts for all the brand ... enjoy a discounted price (up to 30% off) before the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 AttorneyOne.com, a ... all the latest information from the FDA on ... on August 1, that Organic Raw Carob Powder sold ... recalled due to possible contamination with Salmonella. ... with weakened immune systems. In healthy people it can ...
(Date:8/27/2014)... Crossing, PA (PRWEB) August 27, 2014 Time ... successfully launched its first-ever golf event! , With 80-degree ... for the Time To Play Golf (TTPGolf) Inaugural Outing. Around ... August 4th event, staged at the beautiful Heron Glen Golf ... with a bang and everyone seemed to be having a ...
(Date:8/27/2014)... OR (PRWEB) August 27, 2014 The ... improve quality of life and may eliminate the need ... controversy. During a recent AllMed webinar, Dr. Zanhua Yi, ... issues related to determining medical necessity of erythropoiesis-stimulating agents ... disease (CKD). , The U.S. Food and Drug Administration ...
Breaking Medicine News(10 mins):Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 2Health News:Inc. Magazine Names AvePoint to the Inc. 500|5000 List of Fastest Growing American Companies for the Fifth Consecutive Year 3Health News:Brand New Bamboo Plywoods Now Offered At BambooIndustry.com 2Health News:Organic Raw Carob Powder by Sunburst SuperFoods Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 2Health News:AllMed Webinar Helps Health Plans Determine Medical Necessity Of ESAs In The Treatment Of Chronic Kidney Disease 3
... The Songs of Love ... uplifting, personalized songs for children and teens struggling with a life-threatening ... professionally produced with lyrics containing the child,s name and references to ... Songs are written and performed in the musical style that the ...
... improved hearing and alleviated other symptoms in patients with ... appear in the July 23 New England Journal ... researchers from Massachusetts General Hospital (MGH) report that bevacizumab ... of NF2 patients, the first reported successful NF2 treatment ...
... The world-wide explosion of overweight people has been called ... recognized. Could it really be an epidemic involving an ... increasing prevalence of overweight conditions in our society, investigators ... as a potential direct contributor to obesity. ...
... WASHINGTON, July 8 The results of a study published ... Journal (BMJ) support the findings of a white paper released ... (SCHS) regarding the potentially lifesaving qualities of cholesterol lowering drugs ... "In patients without established cardiovascular disease but with cardiovascular risk ...
... , TROIS-RIVIERES, Quebec, July 8 The Narconon drug rehab ... involved with drug related charges due to their addiction. ... a drug addiction, and just one day gets caught by ... a representative of Narconon Trois-Rivieres. "This is an all ...
... July 8 On the heels of a new campaign launched ... to unsightly "canckles," Dr. Marc Mittleman, founder and director of ... clubs and their members to focus on a real health issue ... in warm, moist environments like locker rooms, communal showers, pool and ...
Cached Medicine News:Health News:Donate Your Car to the Songs of Love Car Donation Program 2Health News:Anti-angiogenesis treatment improves hearing in some NF2 patients 2Health News:Anti-angiogenesis treatment improves hearing in some NF2 patients 3Health News:British Medical Journal Report Supports SCHS White Paper on Statins 2Health News:Drug Crimes in Canada Cause Continuing Problems for Small Communities 2Health News:While Health Clubs Say No to 'Canckles,' Leading Podiatrists Say No to Toenail Fungus 2Health News:While Health Clubs Say No to 'Canckles,' Leading Podiatrists Say No to Toenail Fungus 3
(Date:8/26/2014)... -- Based on its recent analysis of the breast imaging solutions ... North American Frost & Sullivan Award for Technology Innovation Leadership. ... solutions for the early detection of breast cancer. Over the ... solutions and has expanded its global reach to cover ... , Asia and Australia ...
(Date:8/26/2014)... 26, 2014 Novira Therapeutics, Inc., a privately ... of chronic hepatitis B virus (HBV) infection, today announced ... appointed the Chair of its Scientific Advisory Board (SAB). ... Senior Advisor to the Company.  "We ... Chair," said Christian Schade , Chief Executive Officer ...
(Date:8/26/2014)... 2014  Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a ... of Directors has approved the payment of a quarterly cash ... The cash dividend of $0.22 per share will ... of record as of the close of business on September ... of the Board of Directors and may be adjusted as ...
Breaking Medicine Technology:Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 3Novira Therapeutics Announces Appointment of Roger J. Pomerantz, M.D., F.A.C.P., as Chair of Scientific Advisory Board 4
... Calif., Dec. 6 DURECT Corporation,(Nasdaq: ... Phase III trial for Remoxy,had successfully met ... by the U.S. Food and Drug Administration ... an investigational drug based on,DURECT,s patented ORADUR(TM) ...
... Colo., Dec. 5 Replidyne, Inc.,(Nasdaq: RDYN ) ... Collins will participate on the New and Powerful Anti-infectives,panel ... panel,discussion will take place at 11:00 am ET on ... New York City., A live audio webcast of ...
Cached Medicine Technology:Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 2Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 3Primary Endpoint of Pivotal Phase III Clinical Trial Achieved for Remoxy(TM) 4
30 cm - 11 3/4, packages 5 pcs....
Galt Skull Trephine with adjustable centering point and detachable cross-bar handle, 19.0 mm....
23 cm - 9, adult size, for skull thickness up to 12 mm....
Width 3 (76 mm), length 6 3/4 (171 mm). Pattie Tray attaches to long or short arm....
Medicine Products: